News & Analysis on Clinical Trial Services & Contract Research And Development
With the complexities associated with API and HPAPI drug development, it’s necessary to lean on the experts. With Q&A sections, insights and articles addressing the many challenges for biotechs, this eBook is your guide to navigating the drug development pipeline.
Paid for and in partnership with Lonza Small Molecules
Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How can they accelerate timelines and reduce costs?
Paid for and in partnership with Lonza Small Molecules
Applying AI-enabled route scouting services allows drug developers to avoid pitfalls that can typically occur in drug synthesis, speeding up drug substance IND.
Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract
Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug development projects meet tight timelines and budget objectives.
For more product information visit Lonza Small Molecules.